Good efficacy and safety profile of abrocitinib in Chinese adult patients with atopic dermatitis:A case series studyOACSTPCDMEDLINE

To the Editor:Atopic dermatitis(AD)is a chronic,relapsing inflammatory dermatosis with impairment of skin barrier function and immune dysfunction that affects both children and adults.It is characterized by eczematous lesions,pruritus,sleep disturbance,and diminished quality of life.Management of mild AD relies on emollients,topical corticosteroids,topical calcineurin inhibitors,and phototherapy,while systemic corticosteroids,immunosuppressive agents,and biologics are used for severe refractory cases.^([1])Systemic corticosteroids and immunosuppressants have many undesirable side effects.Patients with moderate-to-severe AD who do not respond adequately to topical therapies have few effective treatment options.